177 results
Page 3 of 9
8-K
EX-99
wzcjoiu xrcbm1z9s
5 Nov 20
Results of Operations and Financial Condition
4:43pm
8-K
EX-99
yrslfl aa2v6
26 Aug 20
Departure of Directors or Certain Officers
6:46am
8-K
EX-4.1
ezgogr1 kkpnn4qi
7 Aug 20
Emergent BioSolutions Announces Successful Completion of Offering of 3.875% Senior Unsecured Notes Due 2028
4:33pm
8-K
EX-99
fupn vpa3oel6q3wf
7 Aug 20
Emergent BioSolutions Announces Successful Completion of Offering of 3.875% Senior Unsecured Notes Due 2028
4:33pm
8-K
EX-4.1
wgahd4 otuml52l4tk6
7 Aug 20
Emergent BioSolutions Announces Successful Completion of Offering of 3.875% Senior Unsecured Notes Due 2028
4:29pm
8-K
EX-99
eaxak90qmtj66n
7 Aug 20
Emergent BioSolutions Announces Successful Completion of Offering of 3.875% Senior Unsecured Notes Due 2028
4:29pm
8-K
EX-99
pgus sw9nvp
5 Aug 20
Other Events
12:00am
8-K
EX-99
t5vns4jpz7sp2h
31 Jul 20
Results of Operations and Financial Condition
4:28pm
8-K
EX-99
w0i94g5vp27wfoxkq9
27 Jul 20
Entry into a Material Definitive Agreement
6:50am
8-K
EX-99
aec0 7rwdcq
6 Jul 20
Entry into a Material Definitive Agreement
6:43am
8-K
EX-99
h2c u87jt2
11 Jun 20
Emergent BioSolutions Signs Agreement to be U.S. Manufacturing Partner for AstraZeneca’s COVID-19 Vaccine Candidate
4:39pm
8-K
EX-99
kosxjk 0id
8 Jun 20
Regulation FD Disclosure
6:29am
8-K
EX-99
rhggh60y
1 Jun 20
Entry into a Material Definitive Agreement
8:45am
8-K/A
EX-99.1
lwuom8 c3
30 Apr 20
Emergent Biosolutions Reports Financial Results for First Quarter 2020
9:54pm
8-K
EX-99.1
pdv0c99v8jh86p3
30 Apr 20
Emergent Biosolutions Reports Financial Results for First Quarter 2020
4:34pm